Project facts
NEMESIS is co-funded by the Horizon Europe programme of the European Union.
Programme, topic and call
- Programme: HORIZON.2.1 – Health
- Topic: HORIZON-HLTH-2023-ENVHLTH-02-03 – Health impacts of endocrine-disrupting chemicals: bridging science-policy gaps by addressing persistent scientific uncertainties
- Call: HORIZON-HLTH-2023-ENVHLTH-02
Basic information
- Full title: Novel Effect biomarkers for MEtabolic disruptorS: evidence on health Impacts to science and policy needS
- Grant Agreement ID: 101137405
- Duration: 1 January 2024 – 31 December 2028
- Total cost: 7 965 638,75 €, EU grant amount 7 881 685,25 €
- Coordinator: University of Eastern Finland, Professor Jaana Rysä
External Scientific Advisory Board
Åke Bergman
David Dorman
Lisbeth E. Knudsen
Olavi Pelkonen
Suchetana De Storvik
Further information
NEMESIS brochure
Download the NEMESIS brochure (pdf)
